NATICK, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, a leading developer of precision vascular robotics, announced today that the clinical trial of its CorPath® PRECISE (Percutaneous ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. PCI improved angina symptoms at 12 weeks vs. a sham ...

LAS VEGAS (MAY 21, 2019) - Results from a comprehensive analysis demonstrate the effectiveness of measuring a non-hyperemic pressure ratio (NHPR), pressure distal/pressure aortic (Pd/Pa) alongside ...

WALTHAM, Mass.--(BUSINESS WIRE)--Corindus, a Siemens Healthineers company and a leading developer of precision vascular robotics, announced today it has completed the first multi-city, ...

Performing percutaneous coronary intervention (PCI) significantly improved outcomes in patients with stable coronary artery disease (CAD) and severe aortic stenosis selected for transcatheter aortic ...

(UPDATED) A group of leaders in the field of high-risk coronary interventions and their past or current fellows have provided recommendations around what it would take for operators to attain ...

Among centers performing a large number of PCI procedures, the volume of inpatient coronary interventions was not associated with short-term outcomes after either TAVR or transcatheter mitral valve ...

Please provide your email address to receive an email when new articles are posted on . Registry data show transradial access was used for most patients who underwent complex, high-risk PCI.

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Regulators are ...